Outcomes based on plasma biomarkers for the phase III CELESTIAL trial of cabozantinib versus placebo in advanced hepatocellular carcinoma Meeting Abstract


Authors: Zekry, A.; Rimassa, L.; Kelley, R.; Meyer, T.; Ryoo, B.; Merle, P.; Park, J.; Blanc, J.; Lim, H.; Tran, A.; Borgman-Hagey, A.; Clary, D.; Wang, E.; Cheng, A.; El-Khoueiry, A.; Abou-Alfa, G.
Abstract Title: Outcomes based on plasma biomarkers for the phase III CELESTIAL trial of cabozantinib versus placebo in advanced hepatocellular carcinoma
Meeting Title: Australian Gastroenterology Week (AGW)
Journal Title: Journal of Gastroenterology and Hepatology
Volume: 34
Issue: Suppl. 2
Meeting Dates: 2019 Sept 8-10
Meeting Location: Adelaide, Australia
ISSN: 0815-9319
Publisher: Wiley Blackwell  
Date Published: 2019-09-01
Start Page: 41
End Page: 42
Language: English
ACCESSION: WOS:000483843100064
PROVIDER: wos
DOI: 10.1111/jgh.14797
PUBMED: 31484220
Notes: Meeting Abstract: 428 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Ghassan Abou-Alfa
    568 Abou-Alfa